<DOC>
	<DOCNO>NCT01258283</DOCNO>
	<brief_summary>The main objective study determine among patient include subpopulation need defibrillator . This do comparing number discordant segment ( mismatch ) patient severe arrhythmia ( ventricular tachycardia ventricular fibrillation ) appropriate electrical therapy within 3 year monitor others . `` Mismatch '' definition objective usual definition : score 3.4 I123-MIBG ( Iodine 123 metaiodobenzylguanidine ) PET 0,1,2 .</brief_summary>
	<brief_title>PET / CT With 18F-FDG : Does Optimize I 123-MIBG Imaging Results Search Discriminating Factors Implementation Implantable Defibrillator ?</brief_title>
	<detailed_description />
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<mesh_term>3-Iodobenzylguanidine</mesh_term>
	<mesh_term>Deoxyglucose</mesh_term>
	<criteria>Patient ischemic heart disease heart failure Patients receive myocardial perfusion scintigraphy Indication implantation ICD instal accord current recommendation : LVEF &lt; 30 % NYHA ( New York Heart Association ) stage II , III . The subject must give informed consent sign consent The subject must member beneficiary social security system Pregnant lactate woman History `` open heart '' cardiovascular surgery Inability sign inform consent ( patient guardianship ) Patients diabetes mellitus Patient proven dementia Person refuse sign consent Someone already ICD baseline Life expectancy less one year ( NYHA IV , diseases neoplastic disease advance stage )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>